FDA recall record

Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL) recall — FDA D-0723-2021

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Class IIclassification
D-0723-2021official record ID
Aug 18, 2021report date

Recall record at a glance

Official recordD-0723-2021
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmPAI Holdings, LLC. dba Pharmaceutical Associates Inc.
Report dateAug 18, 2021
Recall initiation dateJul 29, 2021
Quantity75 cases (6 bottles/case)
LocationGreenville, SC, United States

Official product description

Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16

Why the product was recalled

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Distribution information

Distributed Nationwide in the USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.